262 related articles for article (PubMed ID: 7670488)
1. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.
Mune T; Rogerson FM; Nikkilä H; Agarwal AK; White PC
Nat Genet; 1995 Aug; 10(4):394-9. PubMed ID: 7670488
[TBL] [Abstract][Full Text] [Related]
2. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
Whorwood CB; Stewart PM
J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
[TBL] [Abstract][Full Text] [Related]
3. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
[TBL] [Abstract][Full Text] [Related]
4. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Agarwal AK
Endocr Rev; 1997 Feb; 18(1):135-56. PubMed ID: 9034789
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
Steroids; 1997 Jan; 62(1):83-8. PubMed ID: 9029720
[TBL] [Abstract][Full Text] [Related]
6. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285
[TBL] [Abstract][Full Text] [Related]
7. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
Rodríguez JA
Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
[TBL] [Abstract][Full Text] [Related]
8. Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase.
Agarwal AK; Rogerson FM; Mune T; White PC
Genomics; 1995 Sep; 29(1):195-9. PubMed ID: 8530071
[TBL] [Abstract][Full Text] [Related]
9. Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency.
Nikkilä H; Tannin GM; New MI; Taylor NF; Kalaitzoglou G; Monder C; White PC
J Clin Endocrinol Metab; 1993 Sep; 77(3):687-91. PubMed ID: 8370690
[TBL] [Abstract][Full Text] [Related]
10. Apparent mineralocorticoid excess.
Funder JW
Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
[TBL] [Abstract][Full Text] [Related]
11. [11 beta-hydroxysteroid-dehydrogenase: characteristics and the clinical significance of a key enzyme in cortisol metabolism].
Kerstens MN; Dullaart RP
Ned Tijdschr Geneeskd; 1999 Mar; 143(10):509-14. PubMed ID: 10321259
[TBL] [Abstract][Full Text] [Related]
12. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene.
Stewart PM; Krozowski ZS; Gupta A; Milford DV; Howie AJ; Sheppard MC; Whorwood CB
Lancet; 1996 Jan; 347(8994):88-91. PubMed ID: 8538347
[TBL] [Abstract][Full Text] [Related]
13. Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess.
Nunez BS; Rogerson FM; Mune T; Igarashi Y; Nakagawa Y; Phillipov G; Moudgil A; Travis LB; Palermo M; Shackleton C; White PC
Hypertension; 1999 Oct; 34(4 Pt 1):638-42. PubMed ID: 10523339
[TBL] [Abstract][Full Text] [Related]
14. A new compound heterozygous mutation in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess.
Kitanaka S; Katsumata N; Tanae A; Hibi I; Takeyama K; Fuse H; Kato S; Tanaka T
J Clin Endocrinol Metab; 1997 Dec; 82(12):4054-8. PubMed ID: 9398712
[TBL] [Abstract][Full Text] [Related]
15. 11 beta-Hydroxysteroid dehydrogenase.
Stewart PM; Krozowski ZS
Vitam Horm; 1999; 57():249-324. PubMed ID: 10232052
[TBL] [Abstract][Full Text] [Related]
16. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform.
Stewart PM; Murry BA; Mason JI
J Clin Endocrinol Metab; 1994 Aug; 79(2):480-4. PubMed ID: 8045966
[TBL] [Abstract][Full Text] [Related]
17. Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype.
Mune T; White PC
Hypertension; 1996 Jun; 27(6):1193-9. PubMed ID: 8641723
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess.
Li A; Tedde R; Krozowski ZS; Pala A; Li KX; Shackleton CH; Mantero F; Palermo M; Stewart PM
Am J Hum Genet; 1998 Aug; 63(2):370-9. PubMed ID: 9683587
[TBL] [Abstract][Full Text] [Related]
19. Apparent mineralocorticoid excess.
Benediktsson R; Edwards CR
J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the human gene encoding the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.
Agarwal AK; Rogerson FM; Mune T; White PC
J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):473-9. PubMed ID: 8547172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]